Table 2 |
|||||
|
R2 in different datasets |
|||||
|
R2 |
|||||
|
|
|||||
|
Poisson linear |
MART |
||||
|
|
|
||||
|
Dataset |
Sub-dataset |
80 nucleotidesa, non-cross-validation |
80 nucleotidesa, cross-validation |
40 nucleotidesa, cross-validation |
40 nucleotidesa, cross-validation |
|
|
|||||
|
Wold |
Brain |
0.52 |
0.51 |
0.51 |
0.70 |
|
Liver |
0.51 |
0.50 |
0.50 |
0.70 |
|
|
Muscle |
0.48 |
0.46 |
0.46 |
0.59 |
|
|
Burge |
Group 1 |
0.43 |
0.42 |
0.42 |
0.52 |
|
Group 2 |
0.37 |
0.35 |
0.35 |
0.46 |
|
|
Group 3 |
0.45 |
0.42 |
0.42 |
0.54 |
|
|
Grimmond |
EB |
0.47 |
0.40 |
0.40 |
0.58 |
|
ES |
0.45 |
0.39 |
0.37 |
0.54 |
|
|
|
|||||
|
aThe lengths of the surrounding sequences we consider. |
|||||
|
Li et al. Genome Biology 2010 11:R50 doi:10.1186/gb-2010-11-5-r50 |
|||||